Literature DB >> 17557495

Systematic review of motor vehicle crash risk in persons with sleep apnea.

Ruth L B Ellen1, Shawn C Marshall, Mark Palayew, Frank J Molnar, Keith G Wilson, Malcolm Man-Son-Hing.   

Abstract

STUDY
OBJECTIVES: To determine whether drivers with sleep apnea are at increased risk of motor vehicle crash; whether disease severity, daytime sleepiness, or both disease severity and daytime sleepiness affect this risk, and whether treatment of sleep apnea reduces crash risk.
DESIGN: Systematic review of published literature.
SETTING: N/A. PATIENTS/PARTICIPANTS: Patients with sleep apnea.
INTERVENTIONS: N/A. MEASUREMENTS AND
RESULTS: Forty pertinent studies were identified. For studies investigating whether noncommercial drivers with sleep apnea have increased crash rates, the majority (23 of 27 studies and 18 of 19 studies with control groups) found a statistically significant increased risk, with many of the studies finding a 2 to 3 times increased risk. Methodologic quality of the studies did not influence this relationship (p = .22). For commercial drivers, only 1 of 3 studies found an increased crash rate, with this association being weak (odds ratio of 1.3). The evidence was mixed regarding whether the risk of crash involvement is proportional to the severity of the sleep apnea, with about half of the studies finding a statistically significant increased risk with increased severity. Correlation with subjective daytime sleepiness and crash risk was also found in only half of the studies reviewed. Treatment of sleep apnea consistently improved driver performance (including crashes) across all studies.
CONCLUSIONS: Noncommercial drivers with sleep apnea are at a statistically significant increased risk of involvement in motor vehicle crashes. Studies did not consistently find that daytime sleepiness and the severity of sleep apnea were correlated with crash risk. Successful treatment of sleep apnea improves driver performance. Clinicians should educate their patients with sleep apnea about the importance of treatment adherence for driving safety.

Entities:  

Mesh:

Year:  2006        PMID: 17557495

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  88 in total

1.  Sleep disturbances and adverse driving events in a predominantly male cohort of active older drivers.

Authors:  Carlos A Vaz Fragoso; Katy L B Araujo; Peter H Van Ness; Richard A Marottoli
Journal:  J Am Geriatr Soc       Date:  2010-10       Impact factor: 5.562

2.  Reliability of a single objective measure in assessing sleepiness.

Authors:  Bernie Y Sunwoo; Nicholas Jackson; Greg Maislin; Indira Gurubhagavatula; Charles F George; Allan I Pack
Journal:  Sleep       Date:  2012-01-01       Impact factor: 5.849

3.  Diagnosing And Treating Co-Morbid Sleep Apnea In Neurological Disorders.

Authors:  Erik K St Louis
Journal:  Pract Neurol (Fort Wash Pa)       Date:  2010-07-01

Review 4.  Continuous positive airway pressure reduces risk of motor vehicle crash among drivers with obstructive sleep apnea: systematic review and meta-analysis.

Authors:  Stephen Tregear; James Reston; Karen Schoelles; Barbara Phillips
Journal:  Sleep       Date:  2010-10       Impact factor: 5.849

5.  Socio-demographic characteristics, health behaviour, co-morbidity and accidents in snorers: a population survey.

Authors:  Peter Torzsa; Andras Keszei; Laszlo Kalabay; Eszter Panna Vamos; Rezso Zoller; Istvan Mucsi; Marta Novak; Maria S Kopp
Journal:  Sleep Breath       Date:  2010-11-14       Impact factor: 2.816

6.  Modafinil improves real driving performance in patients with hypersomnia: a randomized double-blind placebo-controlled crossover clinical trial.

Authors:  Pierre Philip; Cyril Chaufton; Jacques Taillard; Aurore Capelli; Olivier Coste; Damien Léger; Nicholas Moore; Patricia Sagaspe
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

Review 7.  Diagnostic accuracy of level 3 portable sleep tests versus level 1 polysomnography for sleep-disordered breathing: a systematic review and meta-analysis.

Authors:  Mohamed El Shayeb; Leigh-Ann Topfer; Tania Stafinski; Lawrence Pawluk; Devidas Menon
Journal:  CMAJ       Date:  2013-11-11       Impact factor: 8.262

8.  Long-Term Effectiveness and Safety of Maxillomandibular Advancement for Treatment of Obstructive Sleep Apnea.

Authors:  Scott B Boyd; Arthur S Walters; Peter Waite; Susan M Harding; Yanna Song
Journal:  J Clin Sleep Med       Date:  2015-07-15       Impact factor: 4.062

9.  Daytime sleepiness and driving performance in patients with obstructive sleep apnea: comparison of the MSLT, the MWT, and a simulated driving task.

Authors:  Fabio Pizza; Sara Contardi; Susanna Mondini; Lino Trentin; Fabio Cirignotta
Journal:  Sleep       Date:  2009-03       Impact factor: 5.849

10.  Defining the Core Components of a Clinical Review of People Using Continuous Positive Airway Pressure Therapy to Treat Obstructive Sleep Apnea: An International e-Delphi Study.

Authors:  Phyllis Murphie; Stuart Little; Robin Paton; Brian McKinstry; Hilary Pinnock
Journal:  J Clin Sleep Med       Date:  2018-10-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.